Details of Host Protein
| Host Protein General Information (ID: PT0597) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein Name |
Laminin beta-3 chain (LAMB3)
|
Gene Name |
LAMB3
|
||||||
| Host Species |
Homo sapiens
|
Uniprot Entry Name |
LAMB3_HUMAN
|
||||||
| Subcellular Location |
Secreted; extracellular space; extracellular matrix; basement membrane
|
||||||||
| External Link | |||||||||
| NCBI Gene ID | |||||||||
| Uniprot ID | |||||||||
| Ensembl ID | |||||||||
| HGNC ID | |||||||||
| Function in Host |
Binding to cells via a high affinity receptor, laminin isthought to mediate the attachment, migration and organization of cellsinto tissues during embryonic development by interacting with otherextracellular matrix components.
Click to Show/Hide
|
||||||||
| Related KEGG Pathway | |||||||||
| Human papillomavirus infection | hsa05165 |
Pathway Map
|
|||||||
| Toxoplasmosis | hsa05145 |
Pathway Map
|
|||||||
| Amoebiasis | hsa05146 |
Pathway Map
|
|||||||
| PI3K-Akt signaling pathway | hsa04151 |
Pathway Map
|
|||||||
| Focal adhesion | hsa04510 |
Pathway Map
|
|||||||
| Pathways in cancer | hsa05200 |
Pathway Map
|
|||||||
| Small cell lung cancer | hsa05222 |
Pathway Map
|
|||||||
| ECM-receptor interaction | hsa04512 |
Pathway Map
|
|||||||
| 3D Structure |
|
||||||||
| Full List of Virus RNA Interacting with This Protien | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNA Region: ORF10 (hCoV-19/Not Specified Virus Strain ) | |||||||||
| RNA Region Details |
RNA Info
Click to show the detail information of this RNA binding region
|
[1] | |||||||
| Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
| RNA Binding Region |
ORF10
|
||||||||
| Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
| Infection Cells | Calu-3 cells (Human Lung Cancer Cell) (CVCL_0609 ) | ||||||||
| Cell Originated Tissue | Liver | ||||||||
| Interaction Score | P-value < 0.05 | ||||||||
| Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) | ||||||||




